James R. Neal, Director at Processa Pharmaceuticals, Inc. (PCSA), bought 789 shares at $2.54 ($2K) on 2026-03-31, disclosed to the SEC on 2026-04-02.
Open-market purchase of $2k PCSA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| Filing → |
| XOMA | SELL | 2021-06-29 | $543K | — | Filing → |
| XOMA | SELL | 2020-12-17 | $2.1M | — | Filing → |
| XOMA | SELL | 2020-11-24 | $1.3M | — | Filing → |